96 related articles for article (PubMed ID: 10881674)
1. Investigation into the mode of action of R-91650, an arylpiperazinyl fluoroquinolone, on feline immunodeficiency virus replication inhibitory activity.
Kashiwase H; Katsube T; Iida K; Komai T; Nishigaki T; Kimura T; Yamashita M
Arch Virol; 2000; 145(5):859-69. PubMed ID: 10881674
[TBL] [Abstract][Full Text] [Related]
2. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.
Ma J; Kennedy-Stoskopf S; Jaynes JM; Thurmond LM; Tompkins WA
J Virol; 2002 Oct; 76(19):9952-61. PubMed ID: 12208971
[TBL] [Abstract][Full Text] [Related]
4. 8-Difluoromethoxy-4-quinolone derivatives as anti-feline immunodeficiency virus (FIV) agents: important structural features for inhibitory activity of FIV replication.
Kashiwase H; Katsube T; Kimura T; Nishigaki T; Yamashita M
J Vet Med Sci; 2000 May; 62(5):499-504. PubMed ID: 10852398
[TBL] [Abstract][Full Text] [Related]
5. Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.
Egberink HF; De Clercq E; Van Vliet AL; Balzarini J; Bridger GJ; Henson G; Horzinek MC; Schols D
J Virol; 1999 Aug; 73(8):6346-52. PubMed ID: 10400726
[TBL] [Abstract][Full Text] [Related]
6. Application of RNA interference for inhibiting the replication of feline immunodeficiency virus in chronically infected cell lines.
Baba K; Mizukoshi F; Goto-Koshino Y; Setoguchi-Mukai A; Fujino Y; Ohno K; Tsujimoto H
Vet Microbiol; 2007 Mar; 120(3-4):207-16. PubMed ID: 17125939
[TBL] [Abstract][Full Text] [Related]
7. Effects of insertion of multiple AP-1 binding sites into the U3 region of the long terminal repeat of feline immunodeficiency virus.
Miyazawa T; Tomonaga K; Kawaguchi Y; Kohmoto M; Inoshima Y; Maeda K; Mikami T; Maedadel K [corrected to Maeda K]
Arch Virol; 1994; 139(1-2):37-48. PubMed ID: 7529991
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of feline immunodeficiency virus gene expression and replication by alphaherpesvirus ICP4 homologues.
Kawaguchi Y; Maeda K; Miyazawa T; Ono M; Tsubota K; Tomonaga K; Mikami T
J Gen Virol; 1994 Oct; 75 ( Pt 10)():2783-7. PubMed ID: 7931167
[TBL] [Abstract][Full Text] [Related]
9. Modulation of feline immunodeficiency virus infection by stromal cell-derived factor.
Hosie MJ; Broere N; Hesselgesser J; Turner JD; Hoxie JA; Neil JC; Willett BJ
J Virol; 1998 Mar; 72(3):2097-104. PubMed ID: 9499065
[TBL] [Abstract][Full Text] [Related]
10. Mapping the encapsidation determinants of feline immunodeficiency virus.
Kemler I; Barraza R; Poeschla EM
J Virol; 2002 Dec; 76(23):11889-903. PubMed ID: 12414931
[TBL] [Abstract][Full Text] [Related]
11. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
Tanabe T; Yamamoto JK
J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
[TBL] [Abstract][Full Text] [Related]
12. Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties.
Pancino G; Castelot S; Sonigo P
Virology; 1995 Feb; 206(2):796-806. PubMed ID: 7856093
[TBL] [Abstract][Full Text] [Related]
13. Derivatives of 4-amino-3,6-disulfonato-1,8-naphthalimide inhibit reverse transcriptase and suppress human and feline immunodeficiency virus expression in cultured cells.
Rideout D; Schinazi R; Pauza CD; Lovelace K; Chiang LC; Calogeropoulou T; McCarthy M; Elder JH
J Cell Biochem; 1993 Apr; 51(4):446-57. PubMed ID: 7684385
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
Uncini Manganelli RE; Zaccaro L; Tomei PE
J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
[TBL] [Abstract][Full Text] [Related]
15. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
Sparger EE; Shacklett BL; Renshaw-Gegg L; Barry PA; Pedersen NC; Elder JH; Luciw PA
Virology; 1992 Mar; 187(1):165-77. PubMed ID: 1310554
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C.
de Rozières S; Mathiason CK; Rolston MR; Chatterji U; Hoover EA; Elder JH
J Virol; 2004 Sep; 78(17):8971-82. PubMed ID: 15308694
[TBL] [Abstract][Full Text] [Related]
17. Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells.
Schwartz AM; McCrackin MA; Schinazi RF; Hill PB; Vahlenkamp TW; Tompkins MB; Hartmann K
Am J Vet Res; 2014 Mar; 75(3):273-81. PubMed ID: 24564313
[TBL] [Abstract][Full Text] [Related]
18. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
Medinas RJ; Lambert DM; Tompkins WA
J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the replication of feline immunodeficiency virus by lentiviral vector-mediated RNA interference in feline cell lines.
Baba K; Goto-Koshino Y; Mizukoshi F; Setoguchi-Mukai A; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2008 Aug; 70(8):777-83. PubMed ID: 18772551
[TBL] [Abstract][Full Text] [Related]
20. Production of feline immunodeficiency virus in feline and non-feline non-lymphoid cell lines by transfection of an infectious molecular clone.
Miyazawa T; Kawaguchi Y; Kohmoto M; Sakuragi J; Adachi A; Fukasawa M; Mikami T
J Gen Virol; 1992 Jun; 73 ( Pt 6)():1543-6. PubMed ID: 1318947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
